0000842023-12-000005.txt : 20120208 0000842023-12-000005.hdr.sgml : 20120208 20120208132833 ACCESSION NUMBER: 0000842023-12-000005 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120208 FILED AS OF DATE: 20120208 DATE AS OF CHANGE: 20120208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TECHNE CORP /MN/ CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 12580903 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 3 1 primary_doc.xml PRIMARY DOCUMENT X0204 3 2012-02-08 0 0001340652 ChemoCentryx, Inc. CCXI 0000842023 TECHNE CORP /MN/ 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 0 1 0 Series A Preferred Stock Common Stock 2500000 D Series B Preferred Stock Common Stock 973418 D Series C Preferred Stock Common Stock 611574 D Series D Preferred Stock Common Stock 628574 D Convertible Promissory Note Common Stock 1021490 D The Issuer's Preferred Stock has no expiration date, is convertible at any time, in whole or in part, at the election of the holder, and will automatically convert upon the closing of the Issuer's initial public offering (the "IPO") at a conversion ratio of one share of Common Stock for every two shares of Preferred Stock, rounded down to the next whole number, for no additional consideration. The principal amount of the Convertible Promissory Note, plus accrued interest thereon, will automatically convert into shares of Common Stock upon the closing of the IPO at a conversion price of $10.00 per share, the per share amount of the Common Stock being sold in the IPO. Assumes the IPO closing will occur on or about February 13, 2012. Thomas E. Oland, CEO 2012-02-08